Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

Irbesartan

ODYSSEY Outcomes

Odyssey Outcomes - Mortality

The EXPLORER Study

The ACTE Study

NEJM Odyssey Outcomes

The ROSETTE Study

Odyssey Outcomes - PVD Results

Changing trends in VTE: Pulmonary Embolism Cases on Rise within the Last Decade

VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients

Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism

PCSK9 inhibitors and ACS
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources

VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients

Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism

PCSK9 inhibitors and ACS

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Atherosclerotic Cardiovascular Disease Risk Assessment

PCSK9i and Prevention of CVD

APSC Consensus Recommendations on Dyslipidemia

Single-Pill Combinations in Dyslipidemia
%20from%20the%20SAFEHEART%20registry.jpeg 767w, /.imaging/webp/sanofi-platform/img400x300/dam/hcp-portal-gulf/images/science/cardiovascular/dyslipidemia/Clinical-practice-experience-in-patients-with-familial-hypercholesterolemia--FH--from-the-SAFEHEART-registry.jpeg/jcr:content/Clinical%20practice%20experience%20in%20patients%20with%20familial%20hypercholesterolemia%20(FH)%20from%20the%20SAFEHEART%20registry.jpeg 1200w)
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry

PCSK9 Inhibitors in Cardiovascular Disease

VTE Risk Assessment in Surgical Patients

Evaluation of lipid management following ACS
Events
Stay up to date and register for the latest events and view webinar recordings.

CardioRisk WebApp

Venous Thromboembolism Burden

Sanofi Thrombosis Summit

Hypertension and CVD

World Hypertension Day Ep. 1

World Hypertension Day Ep. 2

Dyslipidemia Webinars: Optimizing Dyslipidemia management

06:58
VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

Challenges of VTE Prophylaxis in Surgery

Hypertension - The Most Important Disease in Medicine

Dyslipidemia Webisodes: Mortality data with Prof. Tunon
